Clinical Trials in Texas

Showing 321-340 of 12,973 trials

A Study to Assess the Safety, Pharmacokinetics, and Activity of RO7790121 in Participants With Advanced MASH Liver Fibrosis

NCT06903065

The purpose of this study is to assess the safety, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity and activity of RO7790121 in participants with advanced metabolic dysfunction-associated steatohepatitis (MASH) fibrosis.

MASH

Hoffmann-La Roche50 participantsStarted Apr 2025

Tucson, Arizona, United States • Marietta, Georgia, United States • Bastrop, Louisiana, United States +12 more locations

Active Not RecruitingPhase 342 miles

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome

NCT06684847

The main purpose of the proposed study is to evaluate the efficacy of efgartigimod PH20 SC in patients with moderate-to-severe Primary Sjögren's Disease (pSjD). The study consists of a double-blinded placebo-controlled treatment period and an open-label treatment period. The maximum study duration for participants in both study parts is approximately 105 weeks.

Primary Sjogrens Disease

argenx631 participantsStarted Jan 2025

Scottsdale, Arizona, United States • Sun City, Arizona, United States • Tucson, Arizona, United States +300 more locations

A Study to Assess the Safety, Pharmacokinetics, and Activity of RO7790121 in Participants With Advanced MASH Liver Fibrosis

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome

Find Trials by Condition in Texas

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy

Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy Participants

MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial